Stratifying ALS Patients by Mode of Inheritance Reveals Transcriptomic Signatures Specific to sALS and fALS

Amyotrophic lateral sclerosis (ALS) is a terminal neurodegenerative disease, marked by considerable clinical and molecular heterogeneity. While several genetic drivers have been linked to familial ALS (fALS), the biology of sporadic ALS (sALS)—which accounts for the majority of ALS cases—remains poorly defined. To address this gap, we analyzed 247 bulk mRNA-sequenced post-mortem tissue samples from the lumbar spinal cord and motor cortex and compared expression profiles between fALS, sALS, and controls. Variance-stabilized DEGs from DESeq2 analysis were used as inputs for weighted gene co-expression network analysis (WGCNA). Finally, gene ontology was used to identify transcriptomic signatures and biological pathways unique to sALS and fALS. In the spinal cord, sALS samples exhibited specific downregulation of mitochondrial complex I subunits (e.g., NDUFS8 and NDUFB7) and regulatory genes (e.g., AURKAIP1 and ATP5F1D), suggesting compromised metabolic resilience. In the motor cortex, a co-expression module associated with adaptive immune function and leukocyte infiltration was downregulated in sALS yet upregulated in fALS, indicating distinct inflammatory pathways between these two forms of ALS. Together, our findings highlight that while sALS and fALS are largely the same disease, they exhibit distinct transcriptomic signatures. By accounting for mode of inheritance in study designs—particularly sALS, which represents ~90% of ALS cases—researchers may reveal deeper insights into ALS pathology. This perspective could enable more targeted therapeutic strategies, ultimately improving outcomes for all ALS patients.

• Publication year

  2025

• Venue

  International Journal of Molecular Sciences

• Publication date

  2025-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/ijms26189234PMID 41009796PMCID 12470382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ALS molecular subtypes are a combination of cellular and pathological features learned by deep multiomics classifiers

  2025cited by this paper
• Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS Registry

  2025cited by this paper
• Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD

  2024cited by this paper
• The natural history of ALS: Baseline characteristics from a multicenter clinical cohort

  2023cited by this paper
• Managed care considerations to improve health care utilization for patients with ALS.

  2023influential reference
• The amyotrophic lateral sclerosis exposome: recent advances and future directions

  2023cited by this paper
• Prevalence of amyotrophic lateral sclerosis in the United States, 2018

  2023cited by this paper
• Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis

  2023cited by this paper
• Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review

  2023cited by this paper
• Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis

  2022cited by this paper
• Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials

  2022cited by this paper
• Amyotrophic Lateral Sclerosis Risk Genes and Suppressor.

  2022cited by this paper
• Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016

  2021cited by this paper
• Harnessing the power of the electronic health record for ALS research and quality improvement: CReATe CAPTURE‐ALS and the ALS Toolkit

  2021cited by this paper
• Unraveling the complex interplay between genes, environment, and climate in ALS

  2021cited by this paper
• Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses

  2020cited by this paper
• Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis

  2020cited by this paper
• Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia

  2019influential reference
• The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis

  2018cited by this paper
• Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences

  2018influential reference
• Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches

  2018cited by this paper
• The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States

  2017cited by this paper
• Amyotrophic Lateral Sclerosis.

  2017cited by this paper
• Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS).

  2017cited by this paper
• Amyotrophic lateral sclerosis

  2017cited by this paper
• Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.

  2016cited by this paper
• Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers

  2016cited by this paper
• SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis

  2015cited by this paper
• State of play in amyotrophic lateral sclerosis genetics

  2013cited by this paper
• Fast R Functions for Robust Correlations and Hierarchical Clustering.

  2012cited by this paper
• Functional organization of the transcriptome in human brain

  2008cited by this paper

• No citing papers are available for this paper.